Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial
HPTN 067 (ADAPT) study team
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
55
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adult Women
22%
African Women
100%
Cape Town
100%
Daily Dose
11%
Daily Regimen
66%
Daily Use
11%
Directly Observed
22%
Drug Concentration
11%
Emtricitabine
22%
High Coverage
11%
HIV Pre-exposure Prophylaxis
11%
HIV Research Network
11%
HIV Seroconversion
11%
Intention-to-treat
11%
Limit of Quantification
11%
Nondaily
100%
Odds Ratio
11%
One Dose
22%
Oral Pre-exposure Prophylaxis
11%
Phase II Clinical Trial
11%
Phase II Trial
100%
Pre-exposure Prophylaxis (PrEP)
100%
Random Assignment
11%
South Africa
11%
Tenofovir Disoproxil Fumarate
22%
Time Event
11%
Time-driven
88%
Unblinding
11%
Women Age
22%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
33%
Drug Concentration
33%
Emtricitabine Plus Tenofovir Disoproxil
66%
HIV
100%
Side Effect
66%
Symptom
33%
Tablet
33%